Personalised medicine: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is cost effective in spondyloarthritis and psoriatic arthritis
Sayam Dubash, Domini Bryer, Andrew Barr, John Fitton, Claire Wenham, Helena Marzo-Ortega and Jane Freeston
DOI: https://doi.org/10.7861/clinmedicine.19-2-s108
Clin Med March 2019 Sayam Dubash
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Domini Bryer
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Andrew Barr
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
John Fitton
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Claire Wenham
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Helena Marzo-Ortega
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Jane Freeston
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Article Information
vol. 19 no. Suppl 2 108-109
Published By:
Print ISSN:
Online ISSN:
History:
- Published online May 30, 2019.
Copyright & Usage:
© Royal College of Physicians 2019. All rights reserved.
Author Information
Article usage
Article Tools
Personalised medicine: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is cost effective in spondyloarthritis and psoriatic arthritis
Sayam Dubash, Domini Bryer, Andrew Barr, John Fitton, Claire Wenham, Helena Marzo-Ortega, Jane Freeston
Clinical Medicine Mar 2019, 19 (Suppl 2) 108-109; DOI: 10.7861/clinmedicine.19-2-s108
Citation Manager Formats
Personalised medicine: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is cost effective in spondyloarthritis and psoriatic arthritis
Sayam Dubash, Domini Bryer, Andrew Barr, John Fitton, Claire Wenham, Helena Marzo-Ortega, Jane Freeston
Clinical Medicine Mar 2019, 19 (Suppl 2) 108-109; DOI: 10.7861/clinmedicine.19-2-s108
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.